Space Peptides, a Space Pharmaceuticals company, completes GMP-like inspection by China’s National Medical Products Administration (NMPA, previously called CFDA)
Space Peptides, a Space Pharmaceuticals company, successfully completes the GMP inspection carried out by China’s regulatory agency National Medical Products Administration (NMPA, previously called CFDA). The comprehensive inspection covered the Space Peptides Xiamen facility’s quality processes and entire production system., which meets the requirements for producing peptide intermediates / advanced intermediates and active pharmaceutical ingredients […]